These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3941461)

  • 1. Prophylaxis and therapy of an experimental bladder cancer with biological response modifiers.
    Morales A; Pang AS
    J Urol; 1986 Jan; 135(1):191-3. PubMed ID: 3941461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
    BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer.
    Shapiro A; Ratliff TL; Oakley DM; Catalona WJ
    J Urol; 1984 Jan; 131(1):139-42. PubMed ID: 6418894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological protection induced by bacillus Calmette-Guérin treatment in a murine bladder tumor model.
    Iwasaki A; Kawai K; Hayashi H; Ikeda N; Toida I; Ohtani M; Akaza H
    Int J Urol; 2002 Apr; 9(4):219-24. PubMed ID: 12010317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B; Gebhardt M
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells.
    Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C
    J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of murine bladder cancer by irradiated tumor vaccine.
    Lamm DL; Riggs DR; DeHaven JI; Bryner RW
    J Urol; 1991 Jan; 145(1):195-8. PubMed ID: 1984090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations.
    Pang AS; Morales A
    J Urol; 1982 May; 127(5):1006-9. PubMed ID: 7086976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of bladder cancer growth in mice treated with intravesical Bacillus Calmette Guerin and systemic interleukin 2.
    Lee KE; Weiss GH; O'Donnell RW; Cockett AT
    J Urol; 1987 Jun; 137(6):1270-3. PubMed ID: 3495671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.
    Kamat AM; Tharakan ST; Sung B; Aggarwal BB
    Cancer Res; 2009 Dec; 69(23):8958-66. PubMed ID: 19903839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor effect of Bacillus Calmette-Guérin in combination with fibrinogen on urinary bladder tumor.
    Mizutani Y; Nio Y; Fukumoto M; Yoshida O
    J Urol; 1994 May; 151(5):1420-6. PubMed ID: 8158799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of murine transitional cell carcinoma.
    Lamm DL; Reichert DF; Harris SC; Lucio RM
    J Urol; 1982 Nov; 128(5):1104-8. PubMed ID: 6757465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.
    Lee CF; Chang SY; Hsieh DS; Yu DS
    J Urol; 2004 Mar; 171(3):1343-7. PubMed ID: 14767345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of antitumor response. Role of attachment and viability of bacillus Calmette-Guérin to bladder cancer cells.
    Akaza H; Iwasaki A; Ohtani M; Ikeda N; Niijima K; Toida I; Koiso K
    Cancer; 1993 Jul; 72(2):558-63. PubMed ID: 8319187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone.
    Sarosdy MF; Kierum CA
    J Urol; 1989 Nov; 142(5):1376-9. PubMed ID: 2810534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guérin (BCG): A role of BCG internalization into tumor cells.
    Ikeda N; Toida I; Iwasaki A; Kawai K; Akaza H
    Int J Urol; 2002 Jan; 9(1):29-35. PubMed ID: 11972647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA; Chin JL; Batislam E; Karlik SJ; Garcia B; Skamene E
    J Urol; 1997 Aug; 158(2):646-52. PubMed ID: 9224385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.